Purpose:

In order to acquire good stability of an arthroplasty hip, the proper placement of the implants, which prevents impingement between the stem neck and the socket, is important. In general, the anteversion of the uncemented femoral stem depends on the relationship between the three-dimensional structure of the proximal femoral canal and the proximal stem geometry. The exact degree of the anteversion will be known just after broaching during the operation. If the stem anteversion could be forecasted, preoperative planning of the socket placement would be relatively easy. Furthermore, when a high degree of anteversion is forecasted, a special femoral stem to reduce it, such as a modular stem, could be prepared. However, we experienced that the preoperatively measured anteversion of the femoral neck using computer tomography (CT) was sometimes different from that of the stem measured during the operation. The purpose of this study was to investigate whether the preoperative measurement would be helpful to predict the stem anteversion by examining the relationship between the anteversion of the femoral neck and the stem.

Transposition osteotomy of the acetabulum (TOA) was the first periacetabular osteotomy for the osteoarthritis hips due to acetabular dysplasia, in which the acetabulum was transposed with articular cartilage. TOA improves coverage of the femoral head to restore congruity and stability, and also prevent further osteoarthritis deterioration and induce regeneration of the joint. Many good clinical outcomes have been reported for such periacetabular osteotomies for osteoarthritis of the hips at an early stage. In contrast, the clinical outcome is controversial for those hips at an advanced stage, in which the joint space has partly disappeared. The purpose of this study was to investigate whether TOA is an appropriate option for treatment of osteoarthritis of the hips at the advanced stage by comparing with matched control hips at the early stage.

Between 1998 and 2001, TOA was performed in 104 hips of 98 patients.

Sixteen of 17 hips (94%) with osteoarthritis at the advanced stage were examined and compared with 37 matched control hips at the early stage. The mean age at the operation was 48(38–56) and the mean follow-up period was 88 (65–107) months. TOA corrected the acetabular dysplasia and significantly improved containment of the femoral head.

No hips had secondary operations including THA. Clinical scores were also significantly improved in both of the groups. In the advanced osteoarthritis cases, there was a tendency for abduction congruity before transposition osteotomy of the acetabulum to reflect the clinical outcome.

TOA is a promising treatment option for the advanced osteoarthritis of the hips as well as for those patients at the early stage when preoperative radiographs show good congruity or containment of the joint.

Goals of femoral revision arthroplasty are to achieve stability of the femoral component, to restore biomechanical function of the hip joint and to restore the femoral bone stock. In order to accomplish such an ideal revision arthroplasty, several points should be reminded before and during the revision arthroplasty such as exposure, removal of the failed component, restoration of bone loss, placement of the new component and hip stability. Appropriate options of femoral components for revision depend on the degree of femoral bone loss. When the bone loss is minimum, a standard length component can be used like in primary total hip arthroplasty (THA). When it is moderate or severe, special components and techniques would be necessary.

Loss of bone stock is the most difficult problem in femoral revision surgery. It increases a risk of complications during operation such as fracture or perforation, and also results in difficulty to achieve stability of the component. Even when the bone defect is moderate or severe, immediate fixation of the femoral component should be mainly supported by native bone. Additionally, in the remaining bone loss, bone tissue is grafted as much as possible.

Survival rate of revision arthroplasty is low comparing with that of primary THA. In addition to the present revision, a possible next operation in the future should be considered when we plan revision surgery.

Cemented femoral revision has a disadvantage of removal of the prosthesis when it is failed. Removal of cemented component has a high possibility of complications including perforation and fracture. During revision arthroplasty of a cemented femoral component using a modern cement technique, removal of the cement mantle is difficult, time-consuming and hazardous. The cement mass distal to the tip of the femoral component is the most difficult to be removed since it is often well fixed. The removal procedure has a high risk of causing femoral perforation or fracture. Furthermore, in re-revision, the cement fixation will be often beyond the isthmus and into distal bone defect. And revised cemented femoral components would be more difficult to be removed. On the contrary, loosened uncemented components will be removed relatively easily.

Uncemented stem has the advantage of bone stock restoration. Simultaneous bone graft induces restoration of bone stock. Restored bone tissue will support the component, and this improvement of the bone stock would be beneficial when it is failed again in the future.

According to these principles, we prefer uncemented femoral revisions rather than cemented revisions. This paper will show the clinical results of femoral revisions in our department mainly using an uncemented femoral component.

Treating Crowe type 3 or 4 of hips tends to be technically difficult when performing total hip arthroplasty (THA) due to the severely dysplastic acetabulum and proximal femur in addition to a high dislocation of the hip. Since the socket is limited to being placed at the original hip center, a femoral shortening osteotomy is often required in order to prevent neurovascular problems. This osteotomy will need the stability of the femoral stem with both the proximal and the distal femoral bones. We used the modular S-ROM stem, which has a valuable proximal structure and a distal flute structure to stabilize the stem with the proximal and distal femoral fragments. The purpose of this study was to report the clinical and radiographic results of the primary THA with a shortening osteotomy while also using the S-ROM prosthesis.

Between 1994 and 2004, primary THA using the S-ROM prosthesis was performed on 7 hips in 6 cases (1 male, 5 females). Crowe type 3 or 4 was observed in one and 6 hips, respectively. The mean age at operation was 56 years old (range 51~60). The mean follow-up period was 41 months (range 24~56 months). Four hips had previously undergone a subtrochanteric valgus osteotomy. All hips underwent a step-cut femoral osteotomy at the proximal metaphysis for the shortening and/or correction of angulations with on-lay chip bone grafts. All of the used stems were straight type. The clinical outcome was evaluated using the clinical scoring system of hip joints established by the Japanese Orthopaedic Association (JOA). According to a 100 point scale, pain was determined to be 40, ROM was 20, gait was 20 and ADL was 20.

No hips had undergone any revision surgery as of the most recent follow-up. Union was achieved at the osteotomy site in all hips. Neither osteolysis nor a loosening of the implant was radiographically observed. The mean JOA score before THA and at the last follow-up was 41 (31–48) and 81 (62–91) points, respectively. The mean postoperative days to start full weight bearing was 53 days (range 49~70). In two cases (28%), a procedure using circular wiring was performed to treat a crack in the proximal femur.

The S-ROM prosthesis was thus found to be useful for primary THA with a shortening metaphyseal femoral osteotomy for hips in patients with Crowe type 3 or 4 developmental dysplasia.

Transtrochanteric curved varus osteotomy was designed to avoid some of the disadvantages of varus wedge osteotomy, such as post-operative leg-length discrepancy. In this retrospective study we investigated the leg-length discrepancy and clinical outcome after transtrochanteric curved varus osteotomy undertaken in patients with osteonecrosis of the femoral head. Between January 1993 and March 2004, this osteotomy was performed in 42 hips of 36 patients with osteonecrosis of the femoral head. There were 15 males and 21 females with a mean age at surgery of 34 years (15 to 68). The mean follow-up was 5.9 years (2.0 to 12.5). The mean pre-operative Harris hip score was 64.0 (43 to 85) points, which improved to a mean of 88.7 (58 to 100) points at final follow-up. The mean varus angulation post-operatively was 25° (12° to 38°) and the post-operative mean leg-length discrepancy was 13 mm (4 to 25). The post-operative leg-length discrepancy showed a strong correlation with varus angulation (Pearson’s correlation coefficient; r = 0.9530, p < 0.0001), which may be useful for predicting the leg-length discrepancy which can occur even after transtrochanteric curved varus osteotomy.

Purpose: Osseointegration is crucial for favorable outcomes after total hip arthroplasty (THA) using cement-less femoral components. Osseointegration is recognized on radiographs as the endosteal spot weld, which is the bony bridge between the implant and surrounding bone (Engh et al, CORR, 1989). The purpose of this study is to evaluate the clinical and radiographic results for patients who had hydroxyapatite (HA)-coated rough surfaced implants compared with those who had identical implants without HA-coating at three-year minimum follow-up.

Methods: Ninety-one patients, one hundred and two hips who had primary THA with titanium arc sprayed rough surfaced femoral implants were retrospectively studied. Sixty-four hips had received HA-coated implants (HA) and 38 hips had an identical component but without HA (Non-HA). Radiographical parameters analyzed included 1) endosteal spot welds, 2) radiolucent lines, 3) calcar responses, 4) pedestal formation, 5) implant loosening, 6) endosteal osteolysis.

Results: At a minimum follow up of 3 years after operation (mean, 5.5 years), the mean Harris hip score was 89.4 points in the HA group and 89.0 points in the Non-HA group. The radiographic analysis did show the significantly earlier appearance of the endosteal spot welds in HA group. The spot welds at 1 and 2 year after operation were present in 48% and 70% of HA group, while 13% and 42% of Non-HA group. There was no significance at 3 years (71% vs 66%). More than 80% of the spot welds were seen at Gruen zone 6 in the both groups. No differences were noted regarding the radiolucent lines, calcar response, pedestal formation between the groups. There were no implant loosening and osteolysis in both groups.

Conclusions: These results suggest that the use of HA-coating does provide improved fixation in the early periods and the possibility of improved durability.

Introduction: The purpose of this study was to investigate the effects of combination treatments with anticoagulant (warfarin) and a lipid-lowering agent (probucol) on the prevention of steroid-associated osteonecrosis (ON) in rabbits.

Materials and Methods: Male adult Japanese white rabbits were intramuscularly injected once with 20mg/kg body weight of methylprednisolone acetate into the right gluteus medius muscle. These rabbits were divided into three groups: a warfarin plus probucol treatment group (WP Group, n=25), a probucol treatment group (PR Group, n=30), and a non-prophylactic treatment group (NP Group, n=20). Two weeks after the cortico-steroid injection, both femora and humeri were histopathologically examined for the presence of ON, and the sizes of bone marrow fat cells were morphologically examined.

Results: The incidence of ON in the WP Group (5%) was significantly lower than that in the NP Group (70%) (p < 0.0001). The incidence of ON in the PR Group (37%) was significantly lower than that in the NP Group (p < 0.05), but it was significantly higher than that in the WP Group (p < 0.01). The mean size of the bone marrow fat cells was significantly smaller in the WP Group (53.5 ± 4.1μm) than that in the NP Group (60.0 ± 4.0μm) (p < 0.0001). There were no significant differences in the size of bone marrow fat cells between the WP and the PR Groups (52.0 ± 5.0μm).

Discussion: This study experimentally confirmed that anticoagulant plus lipid-lowering agent treatment has a preventative effect on steroid-associated ON in rabbits.

Introduction: When osteonecrosis is located in the medial portion of the femoral head, transtrochanteric curved varus osteotomy (varus), in which the lateral intact area is transposed to the weight-bearing portion, is indicated. The purpose of this study was to evaluate the clinical outcomes of this procedure.

Materials and Methods: Cases consisted of 60 hips in 52 patients with osteonecrosis of the femoral head who had a varus osteotomy from 1981 to 1998. Fifty-five hips out of 60 were followed (follow-up rate: 92%; 5 hips dropped out). The underlying associated factors were alcohol (5), trauma (2), and corticosteroids (40); 8 hips were from patients without a known factor (idiopathic). Nineteen were male and 36 were female. The average age was 34 years at the time of surgery. Forty-three hips were classified as ARCO Stage III-A, 11 in Stage III-B, and 1 in Stage IV.

Results: The average follow-up was 8.1 years (range, 0.8 to 20 years). The average preoperative Harris Hip Score of 51 points improved to an average of 81 at the latest follow-up. Radiographically, osteonecrosis in 46 hips (84%) healed or had no progression of collapse. Nine hips (16%) showed osteoarthritic changes, including progression of collapse, in which 4 cases had undergone conversion to THA. The post-operative intact area ratio in these 4 cases was 16%, while that in the other 51 cases was 70% (p< 0.005).

Discussion: When the intact area remains at the lateral portion of the femoral head, varus osteotomy is useful not only for healing of the necrotic lesion but also for the prevention of osteoarthritis. If the intact area ratio is over 34 % with hip abduction, varus osteotomy is indicated.

Our study describes the mid-term clinical results of the use of transtrochanteric valgus osteotomy (TVO) for the treatment of osteoarthritis of the hip secondary to acetabular dysplasia. The operation included valgus displacement at the level of the lesser trochanter, and lateral displacement of the greater trochanter by inserting a wedge of bone. We reviewed 70 hips. The mean age of the patients at operation was 44 years (14 to 59). Most (90%) had advanced osteoarthritis.

The scores for pain and gait had improved significantly at a mean follow-up of 9.4 years. The rate of survival until an endpoint of a further operation during a follow-up of ten years was 82%. The survival rate was 95% in patients with unilateral involvement who were less than 50 years of age at operation. TVO is a useful form of treatment for advanced osteoarthritis of the hip, particularly in young patients with unilateral disease.

We have studied the correlation between the prevention of progressive collapse and the ratio of the intact articular surface of the femoral head, after transtrochanteric rotational osteotomy for osteonecrosis. We used probit analysis on 125 hips in order to assess the ratio necessary to prevent progressive radiological collapse over a ten-year period. The results show that a minimum postoperative intact ratio of 34% was required. This critical ratio may be useful for surgical planning and in assessing the natural history of the condition.